Duloxetine for the Treatment of Dysthymia
Depressive Disorder
About this trial
This is an interventional treatment trial for Depressive Disorder
Eligibility Criteria
Inclusion Criteria:: Sign an informed consent form 18 years of age or older Females not pregnant or breastfeeding or planning pregnancy and using an acceptable form of contraception Meet DSM-IV criteria for dysthymia A screening IDS-C score of 17 or greater No history of serious or unstable medical disorder Not taking any significant concurrent medications Not currently receiving psychotherapy Exclusion Criteria:- Suffering from DSM-IV defined delirium, dementia, amnestic, or other cognitive disorders mental disorders due to a general medical condition factitious or somatoform disorders mental retardation or developmental disabilities substance or alcohol abuse within the last 3 months depressive disorders with current suicidal risk psychotic disorders including delusional disorder, somatic type dissociative disorder personality disorders sufficiently severe to interfere with study participation History of DSM-IV defined bipolar I or II disorder History of non-response of dysthymia to adequate antidepressant medication History of major depression refractory to two adequate trials of antidepressants
Sites / Locations
- Stanford University School of Medicine